Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2023-04-06
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Treatment for Tinnitus
NCT02632058
Cost-effectiveness of Multidisciplinary Management of Tinnitus
NCT00733044
Modulating Mechanisms in Patients With Chronic Subjective Tinnitus and/or Chronic Pain
NCT05186259
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus
NCT00124800
Randomized Trial Of Tinnitus Retraining Therapy
NCT00578058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tinnitus group
* Adults, i.e. 18-69 year old;
* Pure tone average \<35 dB HL (0.5, 1, 2, 4 kHz);
* Proficient and native speaker of Dutch language;
* Severe unilateral or bilateral tinnitus disorder (TQ \> 46).
No interventions assigned to this group
Control group
* Adults, i.e. 18-69 year old;
* Pure tone average \<35 dB HL (0.5, 1, 2, 4 kHz);
* Proficient and native speaker of Dutch language;
* No tinnitus.
Tinnitus simulation
The control group will perform speech perception tests and listening effort tests in the absence and presence of a simulated tinnitus percept using a bone vibrator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tinnitus simulation
The control group will perform speech perception tests and listening effort tests in the absence and presence of a simulated tinnitus percept using a bone vibrator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pure tone average \<35 dB HL (0.5, 1, 2, 4 kHz);
* Proficient and native speaker of Dutch language;
* TINNITUS GROUP: Severe unilateral or bilateral tinnitus disorder (TQ \> 46).
* CONTROL GROUP: No tinnitus.
Exclusion Criteria
* Significant loss of vision (text on screen at 70 cm should be readable);
* Frequent user of any of the following devices: Hearing Aid, Bone Conduction Device, Cochlear Implant, Tinnitus Masker;
* Additional mental or physical disabilities that may prevent active participation and testing as per protocol.
18 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erwin LJ George, MPE PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht UMC+
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht UMC+
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
301849
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.